Search results (132)
« Back to NewsThe latest news, updates and announcements from the Nuffield Department of Medicine.
Inaugural Sir John Bell Lecture Celebrates a Legacy of Innovation and the Future of Human Health
24 July 2026
Creating a map of every cell in the human body is one of the most ambitious goals in modern science. Through the Human Cell Atlas, an international collaboration involving thousands of researchers worldwide, scientists are building a reference map of human cells that is reshaping understanding of health and disease.
Team ATLAS sets out strategy to investigate cancer avoidance as part of Cancer Grand Challenges
24 July 2026
A new position paper from team ATLAS sets out plans to build a cancer antibody atlas to investigate why some people avoid cancer, while others develop disease.
MORU’s contribution to ASEAN health highlighted during The Princess Royal’s Thailand visit
22 July 2026
The visit highlighted MORU’s longstanding contribution to health across Thailand and the wider ASEAN region, and the value of collaboration between Mahidol University and Oxford's Nuffield Department of Medicine.
UK and France launch landmark biomedical and AI health alliance to accelerate research into major diseases
29 May 2026
A new partnership will unite expertise, infrastructure and data across borders to accelerate diagnosis, treatment and ultimately prevention of major diseases – starting with women’s health, infectious diseases and pandemic preparedness.
Oxford University apprentices celebrated at Oxfordshire Apprenticeship Awards 2026
22 May 2026
Two apprentices from Oxford were recognised at the Oxfordshire Apprenticeship Awards 2026, highlighting the success and impact of apprenticeship opportunities across the Department and the wider University of Oxford.
Academy of Medical Sciences elects three researchers from the Nuffield Department of Medicine as new Fellows
21 May 2026
The Academy of Medical Sciences has elected four University of Oxford biomedical and health scientists to its fellowship in 2026, with three of the researchers based within the Nuffield Department of Medicine.
Oxford University spinout Dark Blue Therapeutics acquired to advance leukaemia treatment
26 March 2026
An Oxford University spinout rooted in Nuffield Department of Medicine and Radcliffe Department of Medicine research was recently acquired by global biotechnology company Amgen in a deal worth up to $840 million. The acquisition highlights how the strength of Oxford’s collaborative, translational research environment, rooted in world leading science, is accelerating the development of potential new targeted treatments for cancers.
Oxford launches AI Cancer Scientist to accelerate cancer vaccine discovery
20 January 2026
The University of Oxford has launched the AI Cancer Scientist, a first-of-its-kind research project exploring whether a closed loop system using artificial intelligence and automation can significantly speed up the early stages of cancer vaccine discovery, supported by funding from the Advanced Research and Invention Agency (ARIA).
Oxford licenses Rift Valley fever vaccine candidate amid West Africa outbreak
13 January 2026
The University of Oxford has licensed an investigational Rift Valley fever vaccine candidate to the Serum Institute of India (SII) as outbreaks of the disease continue in parts of West Africa.
NDM scientists recognised in New Year Honours 2026
5 January 2026
Professor Nicholas Day has been recognised for his long-standing contribution to global health research in the Kings New Years Honours 2026, while Dr Nicky Whiffin has been named in the Times Alternative Honours for her research in rare disease, reflecting the important contribution to global human health from within the Nuffield Department of Medicine.
Oxford University and Brazil Ministry of Health Sign Letter of Intent to Strengthen Cancer Care Across Brazil
15 December 2025
The Ministry of Health of Brazil and Oxford’s Centre for Immuno-Oncology, part of the Nuffield Department of Medicine, have signed a Letter of Intent establishing a broad collaboration to advance cancer research, innovation and clinical translation. The agreement builds on the UK-Brazil Government Health Partnership signed earlier this year, and reflects a shared commitment to accelerating research that will lead to improvements in cancer care across Brazil.
Advancing cancer care: Dr Ignacio Melero awarded ESMO prize for immunotherapy innovation
10 December 2025
The European Society for Medical Oncology (ESMO) has awarded the ESMO Immuno-Oncology Prize to Dr Ignacio Melero, Kidani Professor of Immuno-Therapeutics at the University of Oxford, in recognition of his major contributions to immuno-oncology over recent decades.
Professor Richard White Awarded Academy of Medical Sciences Professorship
20 November 2025
Professor Richard White , a professor in genetics in the Oxford Branch of the Ludwig Institute for Cancer Research, Nuffield Department of Medicine, has been awarded an Academy of Medical Sciences (AMS) Professorship.
Professor Rose McGready recognised for transformative work to improve healthcare for Thai-Myanmar border communities
20 November 2025
Professor Rose McGready, Deputy Director of the Shoklo Malaria Research Unit (SMRU), part of the MORU Tropical Health Network within Oxford’s Nuffield Department of Medicine, has been honoured with the 2026 ACT Australian of the Year Award. The award recognises her extraordinary three decades of service to displaced and marginalised communities along the Thai-Myanmar border, and her clinical and research, that has saved the lives of countless mothers and babies while shaping global standards of care.
Shared Learning in Cancer Research: Brazilian Health Leaders Visit Oxford
18 November 2025
Professor Tim Elliott and colleagues from Oxford Cancer and the Centre for Immuno-Oncology welcomed the Brazilian Minister of Health and senior officials for an official visit organised by the British Embassy in Brazil. The delegation met to exchange insights on cancer research, regulation, and public health, with discussions focusing on prevention, early diagnosis, and innovative treatments such as mRNA vaccines and immunotherapy.
Dr Ignacio Melero recognised for global contribution to advances in cancer immunotherapy
9 November 2025
The Society for Immunotherapy of Cancer (SITC) has honoured Dr Ignacio (Nacho) Melero, Professor of Immunotherapy at NDM's Centre for Immuno-Oncology at Oxford, for his pioneering research transforming cancer treatment through immunotherapy.
Edwine Barasa appointed Director of KEMRI Wellcome Research Programme
8 October 2025
The KEMRI-Wellcome Research Programme (KWTRP) has announced the appointment of Professor Edwine Barasa as its new Director.
Oxford University to accelerate T1D research and care with £10m gift
25 September 2025
The University of Oxford has announced a gift of £10 million from the Bukhman Foundation to support ground-breaking research into type 1 diabetes. This generous funding will establish the Bukhman Centre for Research Excellence in Type 1 Diabetes, as well as create new academic posts and scholarships, helping to accelerate progress towards better treatments and ultimately a cure.
NDM research teams shortlisted for Cancer Grand Challenges
24 September 2025
Two research teams in the Nuffield Department of Medicine have been selected for the final stages of the Cancer Grand Challenges. This includes Professor Xin Lu at Ludwig Oxford in the Cancer Antibody Atlas team and Dr Ricardo Fernandes at the CAMS Oxford Institute as a co-investigator in a team led by the Weizmann Institute.
WHO Collaborating Centre for Genomic Surveillance of AMR launched
5 August 2025
Hosted by the Centre for Genomic Pathogen Surveillance at PSI, the new Centre will support efforts to tackle one of the most pressing global health challenges of our time - antimicrobial resistance.